Please login to the form below

Not currently logged in
Email:
Password:

Icon

This page shows the latest Icon news and features for those working in and with pharma, biotech and healthcare.

Yale Cancer Center joins BMS’ II-ON

Yale Cancer Center joins BMS’ II-ON

Oncology Network (IO-ICON) and the Oncology Academic Research Group (OAR).

Latest news

  • Lilly pilots enhanced online trial information Lilly pilots enhanced online trial information

    Approaching this issue Lilly's Naas explained: “ We tried to avoid using complex medical terms and jargon and opted instead to illustrate study procedures using icons and symbols rather than words. “

  • ICON boosts leadership teams ICON boosts leadership teams

    ICON boosts leadership teams. Dr Andrew Garrett, Dr Paul McCracken and Jim Carroll join. ... Pharmaceutical service provider ICON has boosted its scientific operations, medical imaging and real world evidence leadership teams with three new senior

  • Paywatch and the market access waters Paywatch and the market access waters

    to market access,” says James Eaton, principal, health economics, ICON Commercialisation &Outcomes. “ ... A good partner can predict exactly how payers will react to particular trial designs or product profiles,” says Catherine Beecher, principal,

  • IBM adds to healthcare capabilities with Truven buy IBM adds to healthcare capabilities with Truven buy

    and a clinical trial recruitment collaboration with ICON.

  • Less is more: how risk-based monitoring is changing trials Less is more: how risk-based monitoring is changing trials

    We are encouraging our customers to move to the more patient-centric risk-based approach,” says Steven Cutler, chief operating officer of ICON, who indicated that interest in RBM is growing ... It's certainly moving faster than electronic data capture

More from news
Approximately 7 fully matching, plus 37 partially matching documents found.

Latest Intelligence

  • Proving real-world value Proving real-world value

    Best-in-class operating model. Ramita Tandon, executive vice president, ICON Commercialization. &Outcomes, says that current market dynamics present an opportunity for biopharmaceutical companies to develop a novel best-in-class

  • Cell and gene therapies: on course for commercial success? Cell and gene therapies: on course for commercial success?

    is principal, Pricing &Market Access at ICON Commercialisation and Outcomes. 20th February 2017.

  • Stepping up to payer-driven market access Stepping up to payer-driven market access

    James Eaton is senior principal, health economics and Catherine Beecher is divisional principal, pricing and market access, ICON Commercialisation &Outcomes.

  • The price is right? The price is right?

    But it's an incredibly complex process. “ Market access cannot be separated from price,” says Stuart Tutt, global head of ICON Pricing and Market Access. “

  • Deal Watch table for April 2014 Deal Watch table for April 2014

    Aptiv Solutions/ ICON. Acquisition. CRO/ Adaptive Clinical Trials. 143.5. California Stem Cell/ NeoStem.

More from intelligence
Approximately 2 fully matching, plus 4 partially matching documents found.

Latest appointments

  • RJW & Partners appoints new director RJW & Partners appoints new director

    RJW &Partners appoints new director. Cathy Beecher joins from ICON. Pricing and market access group RJW &Partners, a subsidiary of Mission Group, has appointed Cathy Beecher as its new director. ... She joins the firm from pharma service provider ICON,

  • PharmaLex strengthens international team PharmaLex strengthens international team

    He joins the group from ICON, where he was vice president, global business development early phase services.

  • Teckro appoints Dana Poff as COO Teckro appoints Dana Poff as COO

    Teckro appoints Dana Poff as COO. She joins the Irish group from ICON. ... Poff joins the Limerick, Ireland-based group from ICON, a clinical research organisation, where she held leadership roles in clinical operations, project management and alliance

  • PharmaLex Group strengthens development consulting team PharmaLex Group strengthens development consulting team

    Most recently, Belcher served as head of global regulatory affairs at ICON, having been promoted from vice president in 2014.

  • Quanticate names chief operating officer Quanticate names chief operating officer

    Previously, Morgan served as ICON's group president for clinical research services, and has held a number of finance management roles atMDS and RPS.

More from appointments
Approximately 7 fully matching, plus 11 partially matching documents found.

Latest from PMHub

  • Experience design of physical spaces: a human-centred approach

    landmarks, walking directions and paths, as well as intuitive icons, symbols, and terminology).

  • Health literacy... it’s not just plain English

    By keeping the website design clean and using splashes of colour for the icons and graphics alongside the use of simple language, we ensured that key points are not lost in

  • The healthcare market research themes for 2014

    mind response, or using icons to replace dry number-rating scales, a range of smiling to frowning faces to indicate satisfaction or dissatisfaction or star ratings.

  • ICON Plc

    ICON Plc. ICON is a global provider of outsourced development services that span the entire lifecycle of product development, from compound selection to Phase I-V clinical studies, outcomes research, market ... Telephone:353-1-2912000. Address:. ICON plc.

  • Clinical research

    ICON is a global provider of outsourced development services that span the entire lifecycle of product development, from compound selection to Phase I-V clinical studies, outcomes research, market access and

More from PMHub
Approximately 0 fully matching, plus 6 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
COUCH.

WE ARE COUCH – a full service medical communications agency. We are a trusted partner; always striving to help make...

Latest intelligence

The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
Unique forum will unite NHS and industry to drive innovation
HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare...

Infographics